Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining.
Wang PL, Teng L, Feng YC, Yue YM, Han MM, Yan Q, Ye K, Tang CX, Zhang SN, Fei Qi T, Zhao XH, La T, Zhang YY, Li JM, Hu B, Xu D, Cang S, Wang L, Jin L, Thorne RF, Zhang Y, Liu T, Zhang XD. Wang PL, et al. Among authors: ye k. Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2208904119. doi: 10.1073/pnas.2208904119. Epub 2022 Nov 29. Proc Natl Acad Sci U S A. 2022. PMID: 36445966 Free PMC article.
LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53-Defective Cancer Cells.
La T, Chen S, Zhao XH, Zhou S, Xu R, Teng L, Zhang YY, Ye K, Xu L, Guo T, Jamaluddin MF, Feng YC, Tang HJ, Wang Y, Xu Q, Gu Y, Cao H, Liu T, Thorne RF, Shao FM, Zhang XD, Jin L. La T, et al. Among authors: ye k. Adv Sci (Weinh). 2023 Mar;10(7):e2204599. doi: 10.1002/advs.202204599. Epub 2023 Jan 13. Adv Sci (Weinh). 2023. PMID: 36638271 Free PMC article.
MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer.
Zheng SM, Feng YC, Zhu Q, Li RQ, Yan QQ, Teng L, Yue YM, Han MM, Ye K, Zhang SN, Qi TF, Tang CX, Zhao XH, Zhang YY, Xu L, Xu R, Xing J, Baker M, Liu T, Thorne RF, Jin L, Preiss T, Zhang XD, Cang S, Gao JN. Zheng SM, et al. Among authors: ye k. Cancer Res. 2024 May 2;84(9):1460-1474. doi: 10.1158/0008-5472.CAN-23-3046. Cancer Res. 2024. PMID: 38593213 Free PMC article.
Research Progress of DCLK1 Inhibitors as Cancer Therapeutics.
Cheng L, Huang S, Chen L, Dong X, Zhang L, Wu C, Ye K, Shao F, Zhu Z, Thorne RF. Cheng L, et al. Among authors: ye k. Curr Med Chem. 2022;29(13):2261-2273. doi: 10.2174/0929867328666210709110721. Curr Med Chem. 2022. PMID: 34254905 Review.
1,765 results